- Home
- Publications
- Publication Search
- Publication Details
Title
AdCD40L—Crossing the Valley of Death?
Authors
Keywords
-
Journal
INTERNATIONAL REVIEWS OF IMMUNOLOGY
Volume 31, Issue 4, Pages 289-298
Publisher
Informa UK Limited
Online
2012-07-18
DOI
10.3109/08830185.2012.692844
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abnormal tumor vasculatures and bone marrow-derived pro-angiogenic cells in cancer
- (2012) Yusuke Mizukami et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Myeloid-derived Suppressor Cells in Cancer Patients
- (2012) Alberto J. Montero et al. JOURNAL OF IMMUNOTHERAPY
- The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab, in the treatment of melanoma
- (2012) Claire Verschraegen Cancer Management and Research
- Redemption for the Field of Oncolytic Virotherapy
- (2011) David H Kirn MOLECULAR THERAPY
- AdCD40L Immunogene Therapy for Bladder Carcinoma--The First Phase I/IIa Trial
- (2010) P.-U. Malmstrom et al. CLINICAL CANCER RESEARCH
- An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood
- (2010) A Danielsson et al. GENE THERAPY
- Platelet CD40L at the interface of adaptive immunity
- (2010) Bennett D. Elzey et al. THROMBOSIS RESEARCH
- Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway
- (2009) R. Lapalombella et al. BLOOD
- Adenovirus delivery of human CD40 ligand gene confers direct therapeutic effects on carcinomas
- (2009) L Vardouli et al. CANCER GENE THERAPY
- Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
- (2009) P.-Y. Pan et al. CANCER RESEARCH
- Growth Inhibition of Human Multiple Myeloma Cells by an Oncolytic Adenovirus Carrying the CD40 Ligand Transgene
- (2009) M. S. Fernandes et al. CLINICAL CANCER RESEARCH
- Antitumor Activity of an Oncolytic Adenoviral-CD40 Ligand (CD154) Transgene Construct in Human Breast Cancer Cells
- (2009) E. M. Gomes et al. CLINICAL CANCER RESEARCH
- Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
- (2009) J. S. Ko et al. CLINICAL CANCER RESEARCH
- Efficient Adenovector CD40 Ligand Immunotherapy of Canine Malignant Melanoma
- (2009) Henrik von Euler et al. JOURNAL OF IMMUNOTHERAPY
- Local AdCD40L Gene Therapy is Effective for Disseminated Murine Experimental Cancer by Breaking T-cell Tolerance and Inducing Tumor Cell Growth Inhibition
- (2009) Camilla Lindqvist et al. JOURNAL OF IMMUNOTHERAPY
- The Janus faces of CD40 in cancer
- (2009) Angelica S.I. Loskog et al. SEMINARS IN IMMUNOLOGY
- Expression of CD40 and growth-inhibitory activity of CD40 ligand in colon cancer ex vivo
- (2008) Yugang Wu et al. CELLULAR IMMUNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started